{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T04:53:35Z","timestamp":1794027215004,"version":"4.8.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer Inc","doi-asserted-by":"publisher","award":["ISR93471557"],"award-info":[{"award-number":["ISR93471557"]}],"id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015825","name":"Korea University Anam Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015825","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jgar.2026.06.023","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T16:50:15Z","timestamp":1783529415000},"page":"209-216","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Molecular characteristics and antimicrobial susceptibility profiling of carbapenem-resistant Pseudomonas aeruginosa clinical isolates in Korea: Implications for novel \u03b2-lactam therapy"],"prefix":"10.1016","volume":"50","author":[{"given":"Yoon Hyun","family":"Sung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Min","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hak Jun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8435-935X","authenticated-orcid":false,"given":"Young Kyung","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2026.06.023_bib0001","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.3390\/antibiotics11081033","article-title":"Treatment heterogeneity in Pseudomonas aeruginosa pneumonia","volume":"11","author":"Caffrey","year":"2022","journal-title":"Antibiot (Basel)"},{"key":"10.1016\/j.jgar.2026.06.023_bib0002","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2024.1374466","article-title":"Antimicrobial resistance of Pseudomonas aeruginosa: navigating clinical impacts, current resistance trends, and innovations in breaking therapies","volume":"15","author":"Elfadadny","year":"2024","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jgar.2026.06.023_bib0003","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2025.1599070","article-title":"Global prevalence and antibiotic resistance profiles of carbapenem-resistant Pseudomonas aeruginosa reported from 2014 to 2024: a systematic review and meta-analysis","volume":"16","author":"Ramatla","year":"2025","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jgar.2026.06.023_bib0004","doi-asserted-by":"crossref","DOI":"10.3346\/jkms.2021.36.e273","article-title":"Antimicrobial susceptibility trends and risk factors for antimicrobial resistance in Pseudomonas aeruginosa bacteremia: 12-year experience in a tertiary hospital in Korea","volume":"36","author":"Kang","year":"2021","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.jgar.2026.06.023_bib0005","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jgar.2024.03.018","article-title":"Risk factors and mortality of carbapenem-resistant Pseudomonas aeruginosa bloodstream infection in haematology department: a 10-year retrospective study","volume":"37","author":"Yuan","year":"2024","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.jgar.2026.06.023_bib0006","doi-asserted-by":"crossref","DOI":"10.1038\/emi.2016.22","article-title":"Mortality attributable to carbapenem-resistant Pseudomonas aeruginosa bacteremia: a meta-analysis of cohort studies","volume":"5","author":"Zhang","year":"2016","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.jgar.2026.06.023_bib0007","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.3390\/antibiotics12111621","article-title":"Resistance in Pseudomonas aeruginosa: a narrative review of antibiogram interpretation and emerging treatments","volume":"12","author":"Giovagnorio","year":"2023","journal-title":"Antibiot (Basel)"},{"key":"10.1016\/j.jgar.2026.06.023_bib0008","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciae403","article-title":"Infectious diseases society of America 2024 guidance on the treatment of antimicrobial-resistant gram-negative infections","author":"Tamma","year":"2024","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2026.06.023_bib0009","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00189-22","article-title":"In vitro activity of ceftolozane-tazobactam, imipenem-relebactam, ceftazidime-avibactam, and comparators against Pseudomonas aeruginosa isolates collected in United States hospitals according to results from the SMART surveillance program, 2018 to 2020","volume":"66","author":"Karlowsky","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2026.06.023_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2024.107134","article-title":"Intravenous fosfomycin in combination regimens as a treatment option for difficult-to-treat infections due to multi-drug-resistant gram-negative organisms: a real-life experience","volume":"63","author":"Meschiari","year":"2024","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jgar.2026.06.023_bib0011","series-title":"Performance standards for antimicrobial susceptibility testing","year":"2023"},{"key":"10.1016\/j.jgar.2026.06.023_bib0013","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0040296","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"4","author":"von Elm","year":"2007","journal-title":"PLoS Med"},{"key":"10.1016\/j.jgar.2026.06.023_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.diagmicrobio.2024.116236","article-title":"Determination of aztreonam\/ceftazidime-avibactam synergism and proposal of a new methodology for the evaluation of susceptibility in vitro","volume":"109","author":"Collar","year":"2024","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jgar.2026.06.023_bib0016","doi-asserted-by":"crossref","first-page":"4783","DOI":"10.1128\/AAC.00574-09","article-title":"Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa","volume":"53","author":"Rodr\u00edguez-Mart\u00ednez","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2026.06.023_bib0017","doi-asserted-by":"crossref","first-page":"4966","DOI":"10.1128\/AAC.02523-13","article-title":"Emergence of VIM-2 and IMP-15 carbapenemases and inactivation of oprD gene in carbapenem-resistant Pseudomonas aeruginosa clinical isolates from Lebanon","volume":"58","author":"Al Bayssari","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2026.06.023_bib0018","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jcma.2017.08.016","article-title":"Investigating of four main carbapenem-resistance mechanisms in high-level carbapenem resistant Pseudomonas aeruginosa isolated from burn patients","volume":"81","author":"Rostami","year":"2018","journal-title":"J Chin Med Assoc"},{"key":"10.1016\/j.jgar.2026.06.023_bib0019","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3343\/alm.2023.43.2.196","article-title":"Emergence of NDM-1-producing Pseudomonas aeruginosa sequence type 773 clone: shift of carbapenemase molecular epidemiology and spread of 16S rRNA methylase genes in Korea","volume":"43","author":"Choi","year":"2023","journal-title":"Ann Lab Med"},{"key":"10.1016\/j.jgar.2026.06.023_bib0020","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3343\/alm.2024.44.1.38","article-title":"Changing genotypic distribution, antimicrobial susceptibilities, and risk factors of urinary tract infection caused by carbapenemase-producing Pseudomonas aeruginosa","volume":"44","author":"Jeong","year":"2024","journal-title":"Ann Lab Med"},{"key":"10.1016\/j.jgar.2026.06.023_bib0021","doi-asserted-by":"crossref","first-page":"418","DOI":"10.3947\/ic.2025.0032","article-title":"Genetic epidemiology and antimicrobial susceptibilities of carbapenem-resistant Pseudomonas aeruginosa isolates from a multicenter study in Korea","volume":"57","author":"Kim","year":"2025","journal-title":"Infect Chemother"},{"key":"10.1016\/j.jgar.2026.06.023_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.106196","article-title":"Pseudomonas aeruginosa epidemic high-risk clones and their association with horizontally-acquired \u03b2-lactamases: 2020 update","volume":"56","author":"Del Barrio-Tofi\u00f1o","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jgar.2026.06.023_bib0023","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1128\/AAC.46.4.1053-1058.2002","article-title":"bla(VIM-2) cassette-containing novel integrons in metallo-beta-lactamase-producing Pseudomonas aeruginosa and Pseudomonas putida isolates disseminated in a Korean hospital","volume":"46","author":"Lee","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2026.06.023_bib0024","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1093\/jac\/dkr381","article-title":"Dissemination of IMP-6 metallo-\u03b2-lactamase-producing Pseudomonas aeruginosa sequence type 235 in Korea","volume":"66","author":"Seok","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2026.06.023_bib0025","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1017\/ice.2021.253","article-title":"Emergence of NDM-producing Pseudomonas aeruginosa among hospitalized patients and impact on antimicrobial therapy during the coronavirus disease 2019 (COVID-19) pandemic","volume":"43","author":"Perez","year":"2022","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jgar.2026.06.023_bib0026","doi-asserted-by":"crossref","first-page":"5272","DOI":"10.1128\/IAI.00546-06","article-title":"Extensive genomic plasticity in Pseudomonas aeruginosa revealed by identification and distribution studies of novel genes among clinical isolates","volume":"74","author":"Shen","year":"2006","journal-title":"Infect Immun"},{"key":"10.1016\/j.jgar.2026.06.023_bib0027","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.MTBP-0016-2017","article-title":"Fitness costs of plasmids: a limit to plasmid transmission","volume":"5","author":"San Millan","year":"2017","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.jgar.2026.06.023_bib0028","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.00008-24","article-title":"Global emergence of double and multi-carbapenemase producing organisms: epidemiology, clinical significance, and evolutionary benefits on antimicrobial resistance and virulence","volume":"12","author":"Yuan","year":"2024","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.jgar.2026.06.023_bib0029","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1348-0421.2009.00137.x","article-title":"Classification of OprD sequence and correlation with antimicrobial activity of carbapenem agents in Pseudomonas aeruginosa clinical isolates collected in Japan","volume":"53","author":"Sanbongi","year":"2009","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.jgar.2026.06.023_bib0030","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.03588-22","article-title":"PorinPredict: in silico identification of OprD loss from WGS data for improved genotype-phenotype predictions of P. aeruginosa carbapenem resistance","volume":"11","author":"Biggel","year":"2023","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.jgar.2026.06.023_bib0031","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.3390\/antibiotics10081012","article-title":"The revival of aztreonam in combination with avibactam against metallo-\u03b2-lactamase-producing gram-negatives: a systematic review of in vitro studies and clinical cases","volume":"10","author":"Mauri","year":"2021","journal-title":"Antibiot (Basel)"},{"key":"10.1016\/j.jgar.2026.06.023_bib0032","doi-asserted-by":"crossref","first-page":"7396","DOI":"10.1128\/AAC.01405-16","article-title":"Siderophore cephalosporin cefiderocol utilizes ferric iron transporter systems for antibacterial activity against Pseudomonas aeruginosa","volume":"60","author":"Ito","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2026.06.023_bib0033","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/jac\/dkaa396","article-title":"Molecular mechanisms driving the in vivo development of OXA-10-mediated resistance to ceftolozane\/tazobactam and ceftazidime\/avibactam during treatment of XDR Pseudomonas aeruginosa infections","volume":"76","author":"Arca-Su\u00e1rez","year":"2021","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2026.06.023_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2023.106744","article-title":"Comparative activity of newer \u03b2-lactam\/\u03b2-lactamase inhibitor combinations against Pseudomonas aeruginosa isolates from US medical centres (2020-2021)","volume":"61","author":"Sader","year":"2023","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jgar.2026.06.023_bib0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1001144","article-title":"Genetic variation shapes protein networks mainly through non-transcriptional mechanisms","volume":"9","author":"Foss","year":"2011","journal-title":"PLoS Biol"},{"key":"10.1016\/j.jgar.2026.06.023_bib0036","doi-asserted-by":"crossref","first-page":"3966","DOI":"10.1016\/j.febslet.2009.10.036","article-title":"Correlation of mRNA and protein in complex biological samples","volume":"583","author":"Maier","year":"2009","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jgar.2026.06.023_bib0037","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/s41579-022-00820-y","article-title":"Molecular mechanisms of antibiotic resistance revisited","volume":"21","author":"Darby","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.jgar.2026.06.023_bib0038","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/microbiolspec.VMBF-0016-2015","article-title":"Mechanisms of antibiotic resistance","volume":"4","author":"Munita","year":"2016","journal-title":"Microbiol Spectr"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716526001062?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716526001062?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T15:53:44Z","timestamp":1790178824000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716526001062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":36,"alternative-id":["S2213716526001062"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2026.06.023","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular characteristics and antimicrobial susceptibility profiling of carbapenem-resistant Pseudomonas aeruginosa clinical isolates in Korea: Implications for novel \u03b2-lactam therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2026.06.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy.","name":"copyright","label":"Copyright"}]}}